Searched for
COPD TREATMENT
Salim Kumar cause of death: National Award-winning Malayalam actor dies at 56. His last Instagram post goes viralMalayalam cinema mourns the loss of National Award-winning actor Salim Kumar, who passed away at 56 after battling a liver-related illness....- Can a cough reveal lung disease? Swaasa AI uses cough sound analysis to screen respiratory disordersAI-powered platform Swaasa is using cough sound analysis through smartphones to help screen respiratory diseases such as COPD, asthma and p...
- Glenmark launches fixed-dose triple therapy for COPDGlenmark Pharmaceuticals has launched a groundbreaking nebulised triple therapy for COPD. This single, easy-to-use treatment combines three...
- AstraZeneca's asthma drug fails 'smoker's lung' studyAstraZeneca's Fasenra failed to reduce flare-ups in COPD patients in a late-stage trial, a setback for the company's efforts to address the...
- Why Smoker's Disease is rising among the millennials and Gen ZsA recent study reveals that COPD, or Smokers' Disease, is impacting younger individuals. Doctors in Delhi are observing a rise in cases amo...
- Verona Pharma stock jumps 20% on $10B Merck deal—can FDA-approved Ohtuvayre reshape COPD care?Verona Pharma stock jumped 20% after Merck announced it will acquire the British biotech in a $10 billion deal. Merck will pay $107 per sha...
- Lupin inks pact with China's Sino Universal Pharmaceuticals for Tiotropium dry powder inhalerLupin Limited partners with Sino Universal Pharmaceuticals. They will commercialize Tiotropium dry powder inhaler in China. This inhaler tr...
- Lupin partners with Honeywell for usage of propellant for inhalersLupin Ltd partners with Honeywell to incorporate 'Solstice Air' propellant in next-generation inhalers for asthma and COPD, aiming to reduc...
- Lupin unit introduces inhaler for asthma patients in GermanyDrug firm Lupin on Friday said its unit has launched a pressurized metered dose inhaler for the treatment of asthma and chronic obstructive...
- Lupin's arm gets UK regulator nod for COPD treatmentGlobal pharma major Lupin Limited on Friday announced that its UK subsidiary, Lupin Healthcare (UK) Limited, has received approval from the...
- What is the cost of diagnosis, treatment for pulmonary diseasesAny disease that affects lungs and parts of the respiratory system is known as pulmonary disease. Brought into the limelight by Covid, also...
- GSK launches once daily, single inhaler-triple therapy for COPD patientsTrelegy is delivered via the innovative Ellipta inhaler that provides accurate dosing through its consistent dose delivery mechanism and is...
- Zydus Pharmaceuticals (USA) Inc gets final US FDA approval to market Roflumilast tabletsRoflumilast tablets are indicated as a treatment to reduce the risk of COPD exacerbations in patients with severe COPD associated with chro...
- Glenmark Pharma launches COPD treatment inhaler in UKDrug firm Glenmark Pharma on Tuesday announced the launch of Tiotropium Bromide Dry Powder Inhaler, used in the treatment of chronic obstru...
- SBI includes Covid-19 treatment under medical insurance scheme for retired employeesThe country's largest bank has also made four other diseases including chronic obstructive pulmonary disease (COPD)/asthma eligible for hos...
- World COPD Day: Quit smoking, wear a mask; incessant coughing, swollen feet are warning signsThe muscles used in breathing might require 10 times more calories than a healthy person.
- Staying indoors can lead to respiratory diseases: 5 ways to improve air quality at work & homeIndoor air pollution can increase the risk of developing COPD.
- AstraZeneca gets marketing nod for asthma drug SymbicortResults from AstraZeneca's two clinical studies have shown that the addition of formoterol to budesonide improved asthma symptoms and lung ...
- New method developed to produce 3D images of lungsThis method could lead to better treatment for chronic obstructive pulmonary disease (COPD) and lung cancer.
- Venus launches new drug in anti-infective segmentVenus Remedies Ltd on Wednesday said it has launched Mucomelt-Forte, an anti-biotic in the domestic market, further enhancing its focus on ...
Load More
